Search
for
Sort by
Research 901–930 of 1000+
- Central precocious puberty secondary to peripheral precocious puberty due to a pineal germ cell tumor: a case and review of literature
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
- 7410 Bevacizumab Induced Hypothyroidism
- Selective Pituitary Resistance to Thyroid Hormone: Clinical Hyperthyroidism with High TSH on Levothyroxine Administration in I-131 Ablated “Graves Disease”
- Evaluation of dihydrotestosterone levels and total testosterone to dihydrotestosterone ratio with clinical symptoms and metabolic parameters in patients with polycystic ovary syndrome
- ODP265 Bph, Androgenic Alopecia, and Acne – Markers of Progesterone Deficiency
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Polycystic Ovary Syndrome (PCOS) and Fertility
- COVID-19 and hypopituitarism
- 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
- High-throughput Sequencing to Identify Monogenic Etiologies in a Preselected Polycystic Ovary Syndrome Cohort
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Hormonal control of 5.ALPHA.-reductase activity in hamster sebaceous glands.
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Treatment of hyperandrogenism in women
- A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
- An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report
- Phenotypic Heterogeneity in 5 Japanese Patients with an Identical Point Mutation in the Vitamin D Receptor Gene
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair Pigmentation
- Inhibition of Hair Growth by Testosterone in the Presence of Dermal Papilla Cells from the Frontal Bald Scalp of the Postpubertal Stumptailed Macaque<sup>1</sup>